Improving cervical cancer screening for underserved women
Official title: Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women
Run by University of Florida · NCT05390567 · Data updated 2026-11-12
This study is testing if personalized cervical cancer screening options and support can help underserved women get the screenings they need.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 25 Years to 65 Years |
| Sex | Women only |
| Enrollment | 800 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Gainesville, Florida) |
| Status | Recruiting |
| Started | June 7, 2024 |
| Main results expected | May 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | August 6, 2026 |
| Trial ID | NCT05390567 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 25 to 65 who have not undergone cervical cancer screening in the past four years and reside in areas served by the Mobile Outreach Clinic.
✕Probably not a fit
Patients with a history of cervical cancer or those who have had a hysterectomy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Project CONTINUITY aims to enhance adherence to cervical cancer screening among underserved women by offering personalized screening options, including HPV self-sampling and in-clinic Pap/HPV testing. The study utilizes community clinical navigators and health workers to provide support and follow-up, addressing social determinants of health that may hinder access to care. Participants will choose their preferred screening method and receive tailored messages and assistance to ensure they complete necessary follow-up care. The project focuses on women living in high socioeconomic vulnerability neighborhoods to improve their screening outcomes.
Why it matters
Potential benefit: If successful, this project could significantly increase cervical cancer screening rates among underserved women, leading to earlier detection and better health outcomes.
How similar studies have gone: Other studies have shown success in using community health workers and personalized approaches to improve cancer screening adherence, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Using the American Cancer Society (ACS) screening recommendations, adults 25 to 65 will be eligible. 2. Assigned sex at birth is female 3. No previous history of cervical cancer 4. No previous history of a hysterectomy 5. Not currently pregnant (self-report) 6. Not currently menstruating\* 7. Have not used any vaginal products (e.g., oil-based lubricants, antifungal, and douches) in prior 2 days\*. Use of vaginal contraceptives, condoms and water-based lubricants are allowed. 8. Have not given birth in the prior 12 weeks\* 9. Self-report they have not undergone cancer screening in the past 4 years or more OR report being past due according to provider recommended screening schedule. 10. Self-report of using the MOC in the past, no current usual source of care OR usual source of care is a non-UFH provider and/or cervical cancer screening is not accessible through that provider 11. Reside in census tracts where the Mobile Outreach Clinic travels. 12. Have a mobile phone or access to a mobile phone that can be used to receive messages or a valid email address. Exclusion Criteria: * For patients who are excluded for criterion 6, 7, and 8, the outreach team (community clinical navigator and CHW) will ask the participant if they can be re-contacted for potential future study eligibility assessment. If the participant agrees, the navigator or CHW will collect contact information to re-contact the participant at a later (pre-determined) date up to 20 weeks later for eligibility screening.
Where it's running
-
University of Florida
Gainesville, Florida, United States Recruiting
Study contacts
- Principal investigator: Ramzi A Salloum, PhD — Division Director, Department of Health Outcomes and Biomedical Informatics, University of Florida; Associate Director, Office of Community Outreach and Engagement, UFHealth Cancer Center
- Study coordinator: Jamie Barrow, MHA, CCRP
- Email: jamiehensley@ufl.edu
- Phone: 352-3253703
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Same-day HPV self-testing with digital cytology triage in Cameroon
This project will test whether HPV self-sampling followed by same-day digital telecytology can quickly find which HPV-positive women aged 30–49 (25–49 if HIV-positive) in Cameroon need treatment.
-
Improving the Pap test experience to boost cervical screening participation
This trial will test whether adding a gentle, non-painful step at the end of a Pap test reduces remembered pain and increases future cervical cancer screening among women aged 25 and older.
-
Two-Door Doulas: Enhanced vs Standard Medicaid Doula Care in Pregnancy
This trial tests whether an enhanced, earlier, and more frequent doula support program helps pregnant people on Medicaid feel less depression and anxiety after birth compared with the standard Medicaid doula care in Florida.
-
Just-in-Time Coping Prompts for College Students
We’re testing whether sending brief coping tips at moments of emotional shift can influence how college students react online, drink, or eat when feelings spike.
-
Momentary Coping Prompts and Hair Steroids in College Students
This trial tests whether sending brief coping prompts at moments of emotional volatility helps college students respond to emotions, while collecting hair samples to see if long-term stress hormones relate to those responses.
-
VM100: a nutritional supplement to see if it improves quality of life for boys with Duchenne
This Phase 2 study tests VM100, a nutritional drink, in boys aged 8 and up with Duchenne muscular dystrophy to see if it can improve quality of life and reduce fatigue.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.